Latest Breaking News On - Fda approval of elranatamab - Page 1 : comparemela.com

Dr Nooka discusses the FDA approval of elranatamab in relapsed/refractory multiple myeloma, key data from MagnetisMM-3, and the evolving role of bispecific antibodies in the multiple myeloma treatment paradigm.

Emory universityUnited statesAshling wahnerAjayk nookaMyeloma programOncology at emory university school of medicineDepartment of hematologyMedical oncologyEmory university schoolWinship dataTechnology applications shared resourceWinship cancer instituteApple podcastsGoogle podcastsAmazon musicFda approval of elranatamab